Liminatus Pharma Earnings
NASDAQ: LIMNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.51-0.30 (-10.68%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 26, 2026
Fiscal period
Sep/2026
Liminatus Pharma earnings summary
Liminatus Pharma is scheduled to report Sep/2026 earnings on Nov 26, 2026. In its most recent report on Nov 19, 2026 (Sep/2026), LIMN posted EPS of $-3.50.
Summary generated from market data by MetaCap's automated system. Methodology
LIMN earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 19, 2026 | — | $-3.50 | — | — |
| Nov 12, 2026 | — | $-3.50 | — | -16.1% |
| Aug 14, 2026 | — | $-0.03 | — | — |
| May 15, 2026 | — | $-0.03 | — | — |
| Mar 31, 2026 | — | $-0.34 | — | — |
| Nov 14, 2025 | — | $-0.07 | — | — |
| Oct 6, 2025 | — | $0.00 | — | — |
| Jun 2, 2025 | — | $-0.02 | — | — |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.